Combinatorial Dna Screening
Patent No. EP4071250 (titled "Combinatorial Dna Screening") was filed by Myriad Womens Health on Mar 21, 2017. The application was issued on Mar 5, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4071250
- Application Number
- EP21214103A
- Filing Date
- Mar 21, 2017
- Status
- Granted And Under Opposition
- Jan 31, 2025
- Publication Date
- Mar 5, 2025
- External Links
- Slate, Register , Google Patents